These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18763854)

  • 1. Influence of endothelin 1 receptor inhibition on functional, structural and molecular changes in the rat heart after irradiation.
    Boerma M; Wang J; Kulkarni A; Roberto KA; Qiu X; Kennedy RH; Hauer-Jensen M
    Radiat Res; 2008 Sep; 170(3):275-83. PubMed ID: 18763854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats.
    Murray DB; Gardner JD; Brower GL; Janicki JS
    Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1251-7. PubMed ID: 18178727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of mast cells on structural and functional manifestations of radiation-induced heart disease.
    Boerma M; Wang J; Wondergem J; Joseph J; Qiu X; Kennedy RH; Hauer-Jensen M
    Cancer Res; 2005 Apr; 65(8):3100-7. PubMed ID: 15833839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y; Oliver JR; Horowitz JD
    Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist.
    Kaddoura S; Firth JD; Boheler KR; Sugden PH; Poole-Wilson PA
    Circulation; 1996 Jun; 93(11):2068-79. PubMed ID: 8640984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ET(A) and ET(B) receptor blockade on post-ischemic cardiac dysfunction and norepinephrine overflow in isolated rat hearts.
    Yamamoto S; Matsumoto N; Kanazawa M; Fujita M; Takaoka M; Matsumura Y
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S394-7. PubMed ID: 15838330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
    Battistini B; Verreault M; Ayach B; Blouin A; Cernacek P; Jeng AY; Wessale J; Opgenorth T; Tsang J
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S386-9. PubMed ID: 15838327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of YM598, a selective endothelin-A receptor antagonist.
    Sudoh K; Yuyama H; Noguchi Y; Fujimori A; Ukai M; Ohtake A; Sato S; Sasamata M; Miyata K
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S390-3. PubMed ID: 15838329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats.
    Lee TM; Chen CC; Lin MS; Chang NC
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1871-9. PubMed ID: 18281380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early endothelin-A receptor blockade decreases blood pressure and ameliorates end-organ damage in homozygous Ren-2 rats.
    Vanêcková I; Kramer HJ; Bäcker A; Vernerová Z; Opocensky M; Cervenka L
    Hypertension; 2005 Oct; 46(4):969-74. PubMed ID: 16157796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion.
    Gonon AT; Erbas D; Bröijersén A; Valen G; Pernow J
    Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1767-74. PubMed ID: 14693683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat.
    Li XS; Wang QD; Pernow J
    Eur J Pharmacol; 1995 Sep; 283(1-3):161-8. PubMed ID: 7498305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release.
    Leskinen H; Vuolteenaho O; Ruskoaho H
    Circ Res; 1997 Jan; 80(1):114-23. PubMed ID: 8978330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro.
    Magga J; Vuolteenaho O; Marttila M; Ruskoaho H
    Circulation; 1997 Nov; 96(9):3053-62. PubMed ID: 9386175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endothelin during reperfusion after ischemia in isolated perfused rat heart.
    Dagassan PH; Breu V; Clozel M; Clozel JP
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):867-74. PubMed ID: 7898067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Mechanical Circulatory Support on Endothelin Receptor Expression in Human Left Ventricular Myocardium from Patients with Dilated Cardiomyopathy (DCM).
    Gärtner F; Abraham G; Kassner A; Baurichter D; Milting H
    PLoS One; 2017; 12(1):e0169896. PubMed ID: 28095452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distortion of K
    Angus JA; Hughes RJA; Wright CE
    Pharmacol Res Perspect; 2017 Dec; 5(6):. PubMed ID: 29226623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
    Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
    Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endothelin system in pulmonary arterial hypertension.
    Galié N; Manes A; Branzi A
    Cardiovasc Res; 2004 Feb; 61(2):227-37. PubMed ID: 14736539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney.
    Benigni A; Zola C; Corna D; Orisio S; Facchinetti D; Benati L; Remuzzi G
    Am J Kidney Dis; 1996 Mar; 27(3):416-23. PubMed ID: 8604712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.